Morales Alberto J, Zadok David, Tardio Edgar, Anzoulatous George, Litwak Sergio, Mora Rolando, Martinez Eduardo, Chayet Arturo S
CODET Aris Vision Institute, Tijuana, Mexico.
J Cataract Refract Surg. 2006 Apr;32(4):595-8. doi: 10.1016/j.jcrs.2006.01.025.
To assess the outcome of simultaneous implantable contact lens (ICL) removal and cataract extraction with pseudophakic intraocular lens (IOL) implantation.
CODET Aris Vision Institute, Tijuana, Mexico.
This retrospective noncomparative interventional case series evaluated 14 eyes of 12 patients with ICL implantations who developed a cataract and simultaneously had ICL removal and cataract extraction with IOL implantation. The follow-up time was at least 6 months (range 6 to 24 months). Visual acuity (logMAR), manifest refraction, intraocular pressure, and adverse events were recorded.
Of the 12 patients (14 eyes), 10 patients (12 eyes) had ICL surgery to correct high myopia and 2 patients (2 eyes), to correct hyperopia. The mean uncorrected visual acuity after ICL implantation (before cataract development), before cataract surgery, and after cataract surgery were 0.48 +/- 0.32, 0.83 +/- 0.34, and 0.40 +/- 0.27, respectively. The mean best corrected visual acuity (BCVA) before ICL implantation, after ICL implantation, and after cataract surgery were 0.31 +/- 0.21, 0.28 +/- 0.19, and 0.27 +/- 0.21, respectively. The mean final manifest spherical equivalent was 0.30 diopters (D) +/- 1.07 (SD) (range +2.38 to 2.0 D). Ten eyes (71.4%) were within +/-1.0 D of the calculated target. One eye had a tear in the posterior capsule with vitreous loss during cataract surgery. No other intraoperative, perioperative, or postoperative complications were observed. No loss of BCVA was recorded at the last postoperative visit.
Lens opacities and cataract formation are a potential complication of ICL surgery. The removal of the ICL and the cataract with IOL implantation was found to be safe, with predictable refractive results.
评估同期取出可植入式接触镜(ICL)并摘除白内障同时植入人工晶状体(IOL)的手术效果。
墨西哥蒂华纳市CODET阿里斯视觉研究所。
本回顾性非对照干预性病例系列研究评估了12例植入ICL后发生白内障的患者的14只眼,这些患者同期接受了ICL取出及白内障摘除并植入IOL手术。随访时间至少6个月(6至24个月)。记录视力(logMAR)、显验光、眼压及不良事件。
12例患者(14只眼)中,10例患者(12只眼)接受ICL手术矫正高度近视,2例患者(2只眼)接受ICL手术矫正远视。ICL植入后(白内障发生前)、白内障手术前及白内障手术后的平均裸眼视力分别为0.48±0.32、0.83±0.34及0.40±0.27。ICL植入前、ICL植入后及白内障手术后的平均最佳矫正视力(BCVA)分别为0.31±0.21、0.28±0.19及0.27±0.21。最终平均显验光球镜等效度为0.30屈光度(D)±1.07(标准差)(范围为+2.38至-2.0 D)。10只眼(71.4%)在计算目标值的±1.0 D范围内。1只眼在白内障手术期间后囊膜撕裂并伴有玻璃体脱出。未观察到其他术中、围手术期或术后并发症。术后最后一次随访时未记录到BCVA下降。
晶状体混浊和白内障形成是ICL手术的潜在并发症。发现取出ICL并摘除白内障同时植入IOL手术是安全的,屈光结果可预测。